https://www.fool.com/investing/2023/12/14/3-stocks-to-buy-before-2024-that-can-set-you-up/?source=iedfolrf0000001
Dec 14, 2023 - These stocks are still relatively cheap, but don't expect them to stay that way for long.
0
fool:759506756515710012
0
https://www.zacks.com/stock/news/2197887/how-to-find-strong-transportation-stocks-slated-for-positive-earnings-surprises?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2197887
Dec 14, 2023 - Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
zc:5875081587455782160
0
https://www.zacks.com/stock/news/2197759/salesforce-crm-adp-tie-up-to-enhance-client-experience?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2197759
Dec 14, 2023 - Salesforce (CRM) and Automatic Data Processing are set to transform client experience by integrating generative artificial intelligence into human capital management.
zc:-5283462148482649782
0
https://www.fool.com/investing/2023/12/14/tesla-stock-up-92-in-2023-but-here-are-2-other-sto/?source=iedfolrf0000001
Dec 14, 2023 - It depends on what it does to replace its pipeline of lithium to produce -- and how much it pays.
0
fool:-5980013401085277321
0
https://www.fool.com/investing/2023/12/13/up-51-in-2023-is-alphabet-stock-a-buy-for-2024/?source=iedfolrf0000001
Dec 13, 2023 - Alphabet is developing artificial intelligence (AI) that will help its search engine and YouTube business segments.
0
fool:-3247508965543258225
0
https://www.zacks.com/stock/news/2197569/ups-revamps-asia-pacific-network-to-boost-regional-business?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2197569
Dec 13, 2023 - UPS' new move to introduce a new intra-Asia flight route will reduce transit times from Singapore and Indonesia to the United States by one business day.
zc:-5773268306458418439
0
https://www.zacks.com/stock/news/2197568/blueprint-bpmc-gets-ec-nod-for-ayvakit-expanded-use-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2197568
Dec 13, 2023 - Blueprint (BPMC) announces EC approval expanding Ayvakit's indication to include the treatment of adult patients with indolent systemic mastocytosis. The stock gained 5%.
zc:-8113738612440637649
0
https://www.zacks.com/stock/news/2197516/ulta-beauty-ulta-up-on-omni-channel-growth-skincare-sales?cid=CS-ZC-FT-analyst_blog|rank_focused-2197516
Dec 13, 2023 - Ulta Beauty (ULTA) is benefiting from healthy traffic trends, greater brand awareness and the expansion of its loyalty program. However, higher supply-chain costs are a headwind.
zc:6207413246328122727
0
https://www.zacks.com/stock/news/2197524/insight-enterprises-nsit-is-up-8-09-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2197524
Dec 13, 2023 - Does Insight Enterprises (NSIT) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-3211604699538782414
0
https://www.zacks.com/stock/news/2197525/icosavax-inc-icvx-is-up-0-10-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2197525
Dec 13, 2023 - Does Icosavax, Inc. (ICVX) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:7305346603622860162
0